Thomas Helleday

33PUBLICATIONS
184CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsBiologically active moleculesCharacterisation of biological macromoleculesCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Jun 10, 2026
Targeting NFATc1-regulated MTHFD2 one-carbon metabolism to suppress sustained T-cell-mediated inflammation in rheumatoid arthritis.

|Jun 02, 2026
Structural basis for uracil removal from DNA by human SMUG1.

|Oct 15, 2025
Giving an Enzyme Scissors: Serotonin Derivatives as Potent Organocatalytic Switches for DNA Repair Enzyme OGG1.

Marek Varga, Florian Ortis, Alicia Del Prado

|Aug 29, 2025
The anabolic steroid stanozolol is a potent inhibitor of human MutT homolog 1.

Emma Scaletti Hutchinson, Robert Gustafsson Westergren, Ingrid Almlöf

|Dec 06, 2024
Coupling cellular drug-target engagement to downstream pharmacology with CeTEAM.

Nicholas C K Valerie, Kumar Sanjiv, Oliver Mortusewicz

|Jun 30, 2024
Kinetic and structural characterization of NUDT15 and NUDT18 as catalysts of isoprene pyrophosphate hydrolysis.

Emma R Scaletti, Judith E Unterlass, Ingrid Almlöf

Pageof 6

Frequent Collaborators

11 joint publications

Pål Stenmark

8 joint publications

Ann-Sofie Jemth

6 joint publications

Oliver Mortusewicz

5 joint publications

Petra Marttila